Company intelligence / Profile preview
Norwell Consumer Healthcare
Montreal, Quebec, Canadanorwellcanada.ca ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Norwell’s OTC products are clinically proven and widely available in Canada, with recent portfolio expansion through acquisition of well-known brands; no traditional drug clinical stage as all products are marketed OTC
- Therapeutic areas
- CardiovascularInfectious DiseasesWomen's HealthOtherGastroenterology
- Modalities
- Small molecule (e.g. mineral salts, acid/alkaline substances, chemical laxatives, phytomedicines)PhytomedicineDevice (nasal gels, topical products)
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Boyd Pharmaceuticals (asset acquisition)Solvotrin (long-term licensing agreement)
Beyond the preview
Go deeper on Norwell Consumer Healthcare.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Norwell Consumer Healthcare.